YAKUGAKU ZASSHI 1980-03-01

[The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione (suxibuzone), antiinflammatory drug. II. The biological fate of suxibuzone (SB) after daily oral administration (author's transl)].

K Taira, Y Yasuda, T Shindo, N Mitani, A Akazawa

文献索引：Yakugaku Zasshi 100(3) , 272-9, (1980)

全文：HTML全文

摘要